Literature DB >> 26012704

Serum amyloid A and inflammation in diabetic kidney disease and podocytes.

Robert J Anderberg, Rick L Meek, Kelly L Hudkins, Sheryl K Cooney, Charles E Alpers, Renee C Leboeuf, Katherine R Tuttle.   

Abstract

Entities:  

Year:  2015        PMID： 26012704      PMCID： PMC5780641          DOI： 10.1038/labinvest.2015.38

Source DB:  PubMed          Journal:  Lab Invest        ISSN： 0023-6837            Impact factor:   5.662


× No keyword cloud information.
Correction to: Laboratory Investigation advance online publication, 22 December 2014; doi: 10.1038/labinvest.2014.163 In this article, the following was added to the Acknowledgments section: The work was supported by Providence Sacred Heart Medical Center and Children’s Hospital, Providence Sacred Heart Medical Center and Children’s Hospital Foundation, and the National Institutes of Health (Grant DK83391).
  9 in total

Review 1.  Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Authors:  Raimund Pichler; Maryam Afkarian; Brad P Dieter; Katherine R Tuttle
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

Review 2.  Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease.

Authors:  Ting Fu; Muthukumar Mohan; Eoin P Brennan; Owen L Woodman; Catherine Godson; Phillip Kantharidis; Rebecca H Ritchie; Cheng Xue Qin
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-17

3.  Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.

Authors:  Pierre-Jean Saulnier; Brad P Dieter; Stephanie K Tanamas; Sterling M McPherson; Kevin M Wheelock; William C Knowler; Helen C Looker; Rick L Meek; Robert G Nelson; Katherine R Tuttle
Journal:  Am J Nephrol       Date:  2017-09-22       Impact factor: 3.754

Review 4.  How immunosuppressive drugs may directly target podocytes in glomerular diseases.

Authors:  Maurizio Salvadori; Aris Tsalouchos
Journal:  Pediatr Nephrol       Date:  2021-07-09       Impact factor: 3.651

5.  Experimental transmission of systemic AA amyloidosis in autoimmune disease and type 2 diabetes mellitus model mice.

Authors:  Mayuko Maeda; Tomoaki Murakami; Naeem Muhammad; Yasuo Inoshima; Naotaka Ishiguro
Journal:  Exp Anim       Date:  2016-06-16

6.  Microarray analysis reveals gene and microRNA signatures in diabetic kidney disease.

Authors:  Chengji Cui; Yabin Cui; Yanyan Fu; Sichao Ma; Shoulin Zhang
Journal:  Mol Med Rep       Date:  2017-11-28       Impact factor: 2.952

7.  Stage II of Chronic Kidney Disease-A Tipping Point in Disease Progression?

Authors:  Lovorka Grgurevic; Rudjer Novak; Grgur Salai; Stela Hrkac; Marko Mocibob; Ivana Kovacevic Vojtusek; Mario Laganovic
Journal:  Biomedicines       Date:  2022-06-27

8.  Duodenal Amyloidosis Masquerading as Iron Deficiency Anemia.

Authors:  Faisal Inayat; Abu Hurairah
Journal:  Cureus       Date:  2016-08-05

9.  Sex Differences in Diabetes- and TGF-β1-Induced Renal Damage.

Authors:  Nadja Ziller; Roland Kotolloshi; Mohsen Esmaeili; Marita Liebisch; Ralf Mrowka; Aria Baniahmad; Thomas Liehr; Gunter Wolf; Ivonne Loeffler
Journal:  Cells       Date:  2020-10-03       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.